Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Analytical, Diagnostic and Therapeutic Techniques and Equipment (2)
- Medical Specialties (2)
- Pharmaceutical Preparations (2)
- Therapeutics (2)
- Anesthesia and Analgesia (1)
-
- Anesthesiology (1)
- Clinical and Medical Social Work (1)
- Health and Medical Administration (1)
- Investigative Techniques (1)
- Medical Education (1)
- Medicinal and Pharmaceutical Chemistry (1)
- Mental Disorders (1)
- Mental and Social Health (1)
- Nursing (1)
- Other Chemicals and Drugs (1)
- Other Psychiatry and Psychology (1)
- Perioperative, Operating Room and Surgical Nursing (1)
- Pharmaceutics and Drug Design (1)
- Pharmacy and Pharmaceutical Sciences (1)
- Psychiatric and Mental Health (1)
- Psychiatry (1)
- Psychiatry and Psychology (1)
- Psychological Phenomena and Processes (1)
- Surgery (1)
- Surgical Procedures, Operative (1)
- Institution
- Publication
- Publication Type
Articles 1 - 3 of 3
Full-Text Articles in Chemicals and Drugs
Ketamine As A Treatment Modality For Treatment-Resistant Depression, Tracy Wulff, Shen Cao
Ketamine As A Treatment Modality For Treatment-Resistant Depression, Tracy Wulff, Shen Cao
Physician Assistant Capstones, 2020-current
Many recent studies have demonstrated the ability of ketamine, an NMDA receptor antagonist, to produce antidepressant effects that may be effective in helping reduce treatment-resistant major depression. In particular, three double-blinded randomized control trials have been conducted to assess the viability and effectiveness of this medication for treatment. This systematic literature review will analyze these studies and determine if the overall research indicates that ketamine is useful in improving depression as measured by the Montgomery–Asberg Depression Rating Scale (MADRS)1.
Objective: Assess the effectiveness of IV Ketamine in reducing treatment-resistant major depressive disorder as measured by the Montgomery–Asberg …
Pain Control: Opioid Vs. Nonopioid Analgesia During The Immediate Postoperative Period, Shamsie M. Lumpkin Bsn, Srna, Isaac W. Parrish Bsn, Srna, Austin S. Terrell Bsn, Srna, Dwayne S. Accardo Dnp, Aprn, Crna
Pain Control: Opioid Vs. Nonopioid Analgesia During The Immediate Postoperative Period, Shamsie M. Lumpkin Bsn, Srna, Isaac W. Parrish Bsn, Srna, Austin S. Terrell Bsn, Srna, Dwayne S. Accardo Dnp, Aprn, Crna
Doctor of Nursing Practice Projects
Background Opioid analgesia has become the mainstay for acute pain management in the postoperative setting. However, the use of opioid medications comes with significant risks and side effects. Due to increasing numbers of prescriptions to those with chronic pain, opioid medications have become more expensive while becoming less effective due to the buildup of patient tolerance. The idea of opioid-free analgesic techniques has rarely been breached in many hospitals. Emerging research has shown that opioid-sparing approaches have resulted in lower reported pain scores across the board, as well as significant cost reductions to hospitals and insurance agencies. In addition to …
Making The Case For Psychedelics: Comparing Alternative Treatment Options For Depression, Nicole Amavisca
Making The Case For Psychedelics: Comparing Alternative Treatment Options For Depression, Nicole Amavisca
Undergraduate Honors Theses
Given the number of people who are treated for depression each year and the knowledge that treatments work differently for everyone, there is a pressing need to provide a variety of treatment options. Although psychedelic research had been halted for a few decades due to recreational abuse, there has been revived interest due to its therapeutic potential in the treatment of mood disorders and addiction. As an example, the hallucinogen ketamine has recently been approved as a treatment for depression, which has opened the door for broadening the discussion on psychedelic research. Although the research is limited, psilocybin mimics ketamine …